Adverse event development in clinical oncology trials - Authors' reply

Lancet Oncol. 2016 Jul;17(7):e264-e265. doi: 10.1016/S1470-2045(16)30245-5.

Authors

Gita Thanarajasingam¹, Jeff A Sloan², Axel Grothey³

Affiliations

¹ Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: [email protected].
² Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA.
³ Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.

PMID: 27396640
DOI: 10.1016/S1470-2045(16)30245-5

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Medical Oncology*